Related Experiment Video
Updated: Mar 12, 2026
12:26
Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
19.4K
P27/CDKN1B Translational Regulators in Pituitary Tumorigenesis
C S Martins1, R C Camargo2, F P Saggioro3
1Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Sao Paulo, Brazil.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|November 9, 2016
Summary
Pituitary tumors show decreased P27 protein, but this is not due to changes in key translational regulators like DKC1 or RPS13. Further research into DKC1 variants is warranted for pituitary tumor development insights.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- P27 (CDKN1B) protein is frequently underexpressed in pituitary tumors.
- The underlying mechanisms, particularly translational regulation, require further investigation.
Purpose of the Study:
- To investigate whether translational regulation contributes to P27 (CDKN1B) underexpression in pituitary adenomas.
- To evaluate the expression of P27 targets and key translational regulators (DKC1, RPS13, miR221, miR222).
- To screen for DKC1 gene variants in pituitary adenomas.
Main Methods:
- Gene and protein expression analysis (RT-PCR, immunohistochemistry) of P27/CDKN1B, CCNE1, CDK2, DKC1, RPS13, miR221, and miR222 in 48 pituitary adenomas and 7 normal pituitaries.
- Sequencing of all 15 exons of the DKC1 gene.
- In silico analysis of identified DKC1 variants.
Main Results:
- P27 protein underexpression was confirmed across all pituitary adenoma subtypes.
- CCNE1 mRNA was overexpressed in nonfunctioning pituitary adenomas (NFPA), but not at the protein level.
- No significant differential gene expression was found for RPS13, DKC1, miR221, or miR222 among the groups.
- Frequent DKC1 single nucleotide polymorphisms (SNPs) were observed, along with rare variants in 11% of tumors, though in silico analysis suggested no deleterious effects.
Conclusions:
- P27 protein underexpression in pituitary adenomas is confirmed, likely involving post-translational mechanisms.
- The expression of P27 translational regulators (DKC1, RPS13, miR221, miR222) does not explain P27 underexpression.
- DKC1 variants are prevalent in pituitary adenomas but their direct role in tumorigenesis remains unclear.
Related Concept Videos
02:34Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
02:34Inhibition of CDK Activity
5.6K
5.6K
01:23Negative Regulator Molecules
38.7K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
02:39Positive Regulator Molecules
7.0K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.0K
01:45Positive Regulator Molecules
136.9K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
136.9K
03:03mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K